期刊文献+

鲎抗脂多糖因子的基因克隆及其在COS-7细胞中的表达

Cloning and expression in COS-7 cells of limulus Anti-Lipopolysaccharide factor Gene from Chinese Horseshoe Crab
下载PDF
导出
摘要 目的构建中国鲎的鲎抗脂多糖因子(LALF)基因序列的真核表达载体并尝试其在真核细胞COS-7中的表达。方法从鲎血细胞中提取mRNA,经RT-PCR扩增出LALF的基因片段,将其克隆入真核表达载体pcDNA3.1/myc-His(-)中进行酶切鉴定和序列测定,重组载体通过脂质体转染COS-7细胞进行表达,SDS-PAGE分析表达产物。结果酶切鉴定和序列分析证实重组质粒含有LALF的基因片段。经RT-PCR证实转染的COS-7细胞含有LALF的基因序列,经SDS-PAGE分析表明转染重组质粒的COS-7细胞表达融合蛋白。结论LALF真核表达载体构建成功并实现其在真核细胞COS-7中的表达,为进一步探讨rLALF的生物活性奠定了基础。 To construct the eukaryotic expression vector containing native LALF(Limulus anti lipopolysaccharide factor) gene from Chinese horseshoe crab and attempt to express the target protein in COS-7 cellls.The mRNA was extracted from amebocytes of Chinese horseshoe crab and the LALF gene sequence was synthesized and amplfied by RT-PCR. The PCR product was cloned into pcDNA3.1/myc-His(-) plasmid and the DNA sequence was examined by restriction enzyme digestion and DNA sequence analysis. The recombinant plasmid was transfected into COS-7 cells by lipofectamine for expression and the positive clones were identified by SDS-PAGE.The LALF gene sequence was confirmed to be present in recombinant plasmid and the transfected COS-7 cells.And the expression of recombinant protein was shown by SDS-PAGE analysis. The construction of eukaryotic expression vector of LALF gene from Chinese horseshoe crab and its expression in COS-7 cells were both successful, which is helpful to the further study on the biological activity of rLALF.
出处 《中国人兽共患病杂志》 CAS CSCD 北大核心 2005年第7期587-591,共5页 Chinese Journal of Zoonoses
基金 福建医科大学苗圃基金(NO.2002M003)
关键词 鲎抗脂多糖因子 真核表达 COS-7细胞 RT-PCR <Keyword>Limulus anti lipopolysaccharide factor (LALF) eukaryotic expression COS-7 cell RT-PCR
  • 相关文献

参考文献13

  • 1Drabick JJ, Bhattacharjee AK, Hoover DL, et al. Covalent polymyxin B conjugate with human immunoglobulin G as an antiendotoxin reagent[J] . Antimicrob Agents Chemother, 1998, 42(3): 583-588.
  • 2Stack AM, Saladino RA, Siber GR, et al. A comparison of bactericidal/permea bility-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats[J] .Crit Care Med, 1997, 25(1): 101-105.
  • 3Nelson D, Kuppermann N, Fleisher GR, et al. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats[J] .Crit Care Med, 1995, 23(1): 92-98.
  • 4Roth RI, Su D, Child AH, et al. Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia[J].J Infect Dis, 1998, 177(2): 388-394.
  • 5Su -Donghui, Roth-RI, Levin-J, et al. Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (LPS) in mice[J] .Critical Care Medicine, 1999, 27(4): 771-778.
  • 6Dankesreiter S, Hoess A, Schneider MJ, et al. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock[J].J Immunol, 2000, 164(9): 4804-4811.
  • 7张秋玉,许伟群,黄爱明,王依星,苏东辉.LALF对增敏小鼠内毒素致死性攻击的保护作用及其对炎症因子产生的调节[J].中国人兽共患病杂志,2003,19(4):54-58. 被引量:4
  • 8Vallespi MG, Glaria LA, Reyes O, et al. A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases [J]. Clin Diagn Lab Immunol, 2000, 7(4): 669-675.
  • 9Wang DN, Chen L, Liu JW, et al. The Native Gene of Anti-Lps Factor from Tachypleus tridentatus: Cloning, Expression and its Bacteriostatic Activity in Vitro[J] .Protein and Peptide Letters, 2001, 8(4):273-280.
  • 10Wainwright NR. Anti-Lps Factor from Horseshoe crabs and Methods of Use. GenBank patent number US5780429-A/1, 14-JUL-1998.

二级参考文献16

  • 1[1]Karima R, Matsumoto S, Higashi H, et al.The molecular pathogenesis of endotoxic shock and organ failure [J].Mol Med Today, 1999, 5(3): 123.
  • 2[2]Natanson C,Hoffman WD, Suffredini AF,et al.Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis [J].Ann Intern Med,1994,120(9):771.
  • 3[3]Roth RI,Su D,Child AH,et al.Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia [J].J Infect Dis,1998,177(2):388.
  • 4[4]Ju DW,Zheng QY,Cao X,et al.Esculentoside A inhibits tumor necrosis factor,interleukin-1,and interleukin-6 production induced by lipopolysaccharide in mice[J].Pharmacology,1998,56(4):187.
  • 5[5]Su D,Roth RI,Levin J.Hemoglobin infusion augments the tumour necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice [J].Critical Care Medicine,1999,27(4):771.
  • 6[6]Titheradge MA.Nitric oxide in septic shock[J].Biochim Biophys Acta,1999,1411(2-3):437.
  • 7[7]Opal SM,DePalo VA.Anti-inflammatory cytokines[J].Chest,2000,117(4): 932.
  • 8[8]Galanos C,Freudenberg MA,and Reutter W.Galactosamine-induced sensitization to the lethal effects of endotoxin[J].Proc Natl Acad Sci USA,1979,76(11):5939.
  • 9[9]Saladino R,Garcia C,Thompson C,et al.Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis [J].Circ Shock,1994,42(2):104.
  • 10[10]Nelson D,Kuppermann N,Fleisher GR,et al.Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats [J].Crit Care Med,1995,23(1): 92.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部